October 31, 2023

Venable LLP

Life Sciences Webinar Series

This event has already occurred.

We are excited to announce Venable’s inaugural Life Sciences Webinar Series. This month-long series will explore the intricacies and latest developments that shape the life sciences industry. Join us as we hear from our seasoned attorneys across various practices who will share insights and provide a framework for navigating the relevant legal landscape.


Closing the Gender Gap

October 3, 2023 | 1:00 pm – 2:00 pm ET

It is widely recognized that there is a strong business case for diversity in corporate leadership. McKinsey & Co. and LeanIn.Org’s Women in the Workplace Report from 2022 discusses the “broken rung” effect, whereby gender representation in entry-level roles may be relatively balanced, but fewer women are promoted to the next level. With fewer candidates in manager and more senior-level roles, there are fewer women in the pipeline to consider for promotion to the C-suite. The report also documents what it calls the “Great Breakup,” referring to the high rate of women leaders stepping away from their companies. The report warns that if companies don’t take action, they won’t just lose women in leadership roles today; they also risk losing the next generation of women leaders as well. During this panel, we will hear what in-house counsel Patricia Barbieri, general counsel of Daiichi Sankyo, Inc., and Stephanie Donahue, principal counsel of patent litigation of Sanofi, are doing to create and expand a diverse pipeline and retain their promising female employees, from entry level to the C-suite. They will also discuss the importance of that retention to business and consumers.


Whitney Meier Howard, Partner, Venable LLP
Kathleen Hardway, Partner, Venable LLP

IP Issues in Business Transactions

October 5, 2023 | 1:00 pm – 2:00 pm ET

Attorneys confront intellectual property issues frequently in the context of a variety of corporate, commercial, and other business transactions. By attending this program, you will acquire, update, or refine an in-depth understanding of IP considerations as they arise in business transactions. The program will begin with a brief update of key developments and will explore the strategic role of IP in a company and its business transactions.

Learn how to assess intellectual property as a strategic asset and how to monetize IP while avoiding costly mistakes.


Alicia Russo, Partner, Venable LLP
Prajakta Sonalker, Partner, Venable LLP

Managing High-Stakes Mass Tort MDLs: Updates and Challenges from the Front Lines

October 10, 2023 | 1:00 pm – 2:00 pm ET

Mass tort MDLs now dominate the federal judiciary dockets as sophisticated third parties fund the development of claims and harvesting of claimants, investing heavily in the “if you build it, they will come” model. Instead of being coordinated pretrial proceedings for the convenience of the parties to promote the just and efficient conduct of the litigation, some inside and outside the judiciary have come to perceive MDLs as settlement programs. Our panel will highlight MDL updates and provide a glimpse into some of the battles being waged to steer MDLs in a new direction.


Jason Rose, Partner, Venable LLP

Legal Developments in Artificial Intelligence: The Intersection of Generative Artificial Intelligence, Intellectual Property, and Privacy Law

October 12, 2023 | 1:00 pm – 2:00 pm ET

The panel will give an overview of how generative artificial intelligence (GAI) intersects with patent, trade secret, copyright, trademark, and privacy law. We will provide an update on the growing list of IP-related cases involving GAI and how the potential outcomes might impact the risks of using GAI and issues that GAI creates for procuring and using patents, trademarks, and copyrights (including the implications related to AI not being able to be an author or an inventor of IP). We will also go over the privacy implications of using GAI, including legal pitfalls, and give some best practice recommendations.


Peter Shapiro, Partner, Venable LLP
Kelly DeMarchis Bastide, Partner, Venable LLP
Heather West, Senior Director of Cybersecurity and Privacy Services, Venable LLP

IPRs, PGRs, and the BPCIA

October 17, 2023 |  1:00 pm – 2:00 pm ET

This presentation will provide an update on PTAB challenges to biologics patents and their interplay with district court litigation. We will discuss recent IPR and PGR decisions, focusing on those most relevant to biologics patents. We will explore how challengers in the biologics space are using PTAB proceedings as a tool and how their use of PTAB proceedings has changed over time, compare outcomes at the PTAB vs. district courts, and look at how the Board and district courts are currently approaching parallel proceedings and motions to stay litigation pending IPRs or PGRs.


Ha Kung Wong, Partner, Venable LLP
Christina Schwarz, Partner, Venable LLP

Product Liability Risk Management Strategies in the Pre and Early Litigation Time Frame

October 19, 2023 | 1:00 pm – 2:00 pm ET

Product safety requires comprehensive risk management strategies that must be implemented before litigation ensues. Attendees will learn strategies for managing and minimizing risks in this critical time frame, as well as practical tips regarding internal company communications, external communications, crisis and brand management, and product recall preparedness.


Erin McCloskey Maus, Partner, Venable LLP
Michael Hecht, Partner, Venable LLP

Navigating the FDA Landscape

October 24, 2023 | 1:00 pm – 2:00 pm ET

This presentation will provide a regulatory law update for drugs, biologics, and medical devices, including tips for product developers to navigate these recent FDA developments.


Justin Coen, Partner, Venable LLP
Jeremiah Kelly, Partner, Venable LLP

Current Trends in Life Sciences and Healthcare Enforcement: Understanding and Anticipating Federal and state investigations and Enforcement Actions

October 26, 2023 | 1:00 pm – 2:00 pm ET

Federal and state governments continue to pour substantial resources into investigating and prosecuting program fraud, kickbacks, false claims, and other violations in the life sciences and healthcare sectors. Our panel will highlight current enforcement initiatives and recent court decisions and settlements, and will provide a sneak peek into the likely near future of enforcement priorities in the life sciences and healthcare.


Warren Hamel, Partner, Venable LLP
Matt Murphy, Partner, Venable LLP
Valerie Cohen, Partner, Venable LLP

Current Trends in ANDA Litigation

October 31, 2023 | 1:00 pm – 2:00 pm ET

During this panel, our presenters will discuss recent trends and current hot topics in Hatch-Waxman litigation, such as obviousness-type double patenting, including the Federal Circuit’s decision on OTDP and patent term adjustment (PTA) in In re Cellect; the increasing prevalence of § 112 written description and enablement challenges; recent inducement case law and trends in non-infringement arguments, and considerations for developing and strengthening patent portfolios in view of these issues.


Erin Austin, Partner, Venable LLP
Zach Garrett, Partner, Venable LLP